RxDoctor Payments Data
★ My doctorsLook up a doctor →

Tamara Guerra Alfonso

Psychiatry · Cutler Bay, FLNPI 1154810661

Payments from drug & device makers

$225,908in general payments, 2019–2025

Across 241 payments — averaging $937.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioxcel Therapeutics, Inc.$221K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$832
  • AbbVie$503
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$481
  • Alkermes, Inc.$450
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$4,60992%
  • Education$4248%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bioxcel Therapeutics, Inc.8$220,875
Teva Pharmaceuticals USA, Inc.35$1,001
Otsuka America Pharmaceutical, Inc.45$832
AbbVie(2 entities)35$503
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)21$481
Alkermes, Inc.22$450
Lundbeck LLC17$395
Neurocrine Biosciences, Inc.11$265
Axsome Therapeutics, Inc.11$248
Supernus Pharmaceuticals, Inc.7$240
Indivior Inc.9$201
Johnson & Johnson5$101
Ironshore Pharmaceuticals Inc.4$85
Tris Pharma Inc3$64
Almatica Pharma LLC2$45
Takeda Pharmaceuticals U.S.A., Inc.2$39
Corium, LLC1$25
Tempus AI, Inc1$21
Exact Sciences1$21
Idorsia Pharmaceuticals US Inc1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$225,908 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole20$29,092
Aripiprazole84$4,714
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$2,522
Escitalopram Oxalate255$2,158
Memantine Hcl150$1,948
Mirtazapine204$1,866
Quetiapine Fumarate134$1,693
Olanzapine25$1,666
Buspirone Hcl145$1,352
Quetiapine Fumarate ErQuetiapine Fumarate29$1,267
Venlafaxine Hcl ErVenlafaxine Hcl34$1,228
Duloxetine Hcl26$1,017
Bupropion XlBupropion Hcl38$481
Clonazepam60$481
Sertraline Hcl223$464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$832$29,09220 claims
Almatica Pharma LLCSertraline Hcl$45$464223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Cutler Bay

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →